In conclusion, we revealed that enhanced Ogt expression could suppress inflammatory carcinogenesis in the colon through inhibition of the NF-κB pathway, implicating that OGT overexpression and the subsequent increased protein O-GlcNAcylation could be new therapeutic targets for colon cancer. This evidence concerns the gene OGT and malignant colon neoplasm.